| Drug Type saRNAs | 
| Synonyms MTL STING | 
| Target | 
| Action agonists | 
| Mechanism STING agonists(Stimulator of interferon genes agonists) | 
| Therapeutic Areas | 
| Active Indication- | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization- | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseDiscontinuedPreclinical | 
| First Approval Date- | 
| Regulation- | 

| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Solid tumor | Preclinical | United Kingdom  | 12 Apr 2022 | 





